In this Book

Prescription for the People: An Activist’s Guide to Making Medicine Affordable for All

Book
Fran Quigley
2017
buy this book Buy This Book in Print
summary

In Prescription for the People, Fran Quigley diagnoses our inability to get medicines to the people who need them and then prescribes the cure. He delivers a clear and convincing argument for a complete shift in the global and U.S. approach to developing and providing essential medicines—and a primer on how to make that change happen.

Globally, 10 million people die each year because they are unable to pay for medicines that would save them. The cost of prescription drugs is bankrupting families and putting a strain on state and federal budgets. Patients' desperate need for affordable medicines clashes with the core business model of the powerful pharmaceutical industry, which maximizes profits whenever possible. It doesn't have to be this way. Patients and activists are aiming to make all essential medicines affordable by reclaiming medicines as a public good and a human right, instead of a profit-making commodity. In this book, Quigley demystifies statistics and terminology, offers solutions to the problems that block universal access to medicines, and provides a road map for activists wanting to make those solutions a reality.

Table of Contents

Cover

Half Title, Series Info, Title Page, Copyright

Contents

pp. vii-x

Acknowledgments

pp. xi-xvi

Introduction

pp. 1-4

Part I. Toxic Impacts

1. People Everywhere Are Struggling to Get the Medicines They Need

pp. 7-12

2. The United States Has a Drug Problem

pp. 13-18

3. Millions of People Are Dying Needlessly

pp. 19-24

4. Cancer Patients Face Particularly Deadly Barriers to Medicines

pp. 25-30

5. The Current Medicine System Neglects Many Major Diseases

pp. 31-34

Part II. Profits over Patients

6. Corporate Research and Development Investments Are Exaggerated

pp. 37-42

7. The Current System Wastes Billions on Drug Marketing

pp. 43-46

8. The Current System Compromises Physician Integrity and Leads to Unethical Corporate Behavior

pp. 47-56

9. Medicines Are Priced at Whatever the Market Will Bear

pp. 57-64

10. Pharmaceutical Corporations Reap History-Making Profits

pp. 65-68

Part III. Patently Poisonous

11. The For-Profit Medicine Arguments Are Patently False

pp. 71-74

12. Medicine Patents Are Extended Too Far and Too Wide

pp. 75-82

13. Patent Protectionism Stunts the Development of New Medicines

pp. 83-86

14. Governments, Not Private Corporations, Drive Medicine Innovation

pp. 87-90

15. Taxpayers and Patients Pay Twice for Patented Medicines

pp. 91-94

Part IV. Trading Away Our Health

16. Medicines Are a Public Good

pp. 97-102

17. Medicine Patents Are Artificial, Recent, and Government-Created

pp. 103-108

18. The United States and Big Pharma Play the Bully in Extending Patents

pp. 109-118

19. Pharma-Pushed Trade Agreements Steal the Power of Democratically Elected Governments

pp. 119-124

Part V. A Better Remedy

20. Current Law Provides Opportunities for Affordable Generic Medicines

pp. 127-136

21. There Is a Better Way to Develop Medicines

pp. 137-146

22. Human Rights Law Demands Access to Essential Medicines

pp. 147-152

Conclusion

pp. 153-172

Notes

pp. 173-236

Index

pp. 237-243
Back To Top